Our blog includes news from LINQ, information about recent events in the projects we work with, and insights into the markets and funding programmes relevant to our projects.
We are currently looking for a Content and Communications Manager to join the LINQ family. Help us create visibility for our projects and the dedicated people behind them!
We are excited to announce that our vaccine network IMPRINT will be funded for another two years by UK Research and Innovation (UKRI).
On 24 and 25 October 2023 the WORMVACs2.0 consortium kicked-off a new 5-year EU-funded project that aims to develop vaccines against schistosome and hookworm infections.
From 02 - 04 October the TB-CAPT consortium convened for a face-to-face progress meeting in Dar-es-Salaam, Tanzania, hosted by our local project partners from Ifakara Health Institute.
The GenPath Africa consortium aims to use genomic epidemiology to better diagnose, monitor and manage current and future epidemics in Africa.
Our new project Vax2Muc sets out to develop improved, innovative, next generation subunit vaccines against diseases caused by AMR mucosal pathogens that colonise the GI tract.
We are delighted to add the GH EDCTP3 JU-funded MARC SE-Africa project to our portfolio, coordinated by Professor Karen I. Barnes of the University of Cape Town in South Africa.
We are excited to welcome Dr Vera Schneider, who joined LINQ as a Senior Advisor on February 1, 2023.
On October 5-6, the StatinTB consortium, led by Prof Reto Guler of the University of Cape Town, convened for the StatinTB year four progress meeting in Cape Town, South Africa
On October 27, the World Health Organization (WHO) published its Global Tuberculosis (TB) Report 2022. We have looked closer at the report findings.